← Back to Analyst Consensus 
AYTU Buy
AYTU BIOPHARMA, INC
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Jun 11, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Dec 10, 2025 | Ascendiant Capital | maintain | Buy → Buy | $13 | 38% |
| Sep 25, 2025 | Maxim Group | maintain | Buy → Buy | $7 | 42% |
| Sep 25, 2025 | Ascendiant Capital | maintain | Buy → Buy | $12.5 | 38% |
| Jul 1, 2025 | Lake Street | initiate | — → Buy | $8 | 47% |
| Jun 30, 2025 | Ascendiant Capital | initiate | — → Buy | $12 | 38% |
| Aug 9, 2023 | Maxim Group | initiate | — → Buy | $5 | 42% |
| May 31, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
Price Target Trend
Apr 2, 2026 Latest: $9.67 Oct 24, 2026
EPS Estimates
0q $-0.18
Lo: $-0.26 Hi: $-0.10
2 analysts 0y $-0.36
Lo: $-0.57 Hi: $-0.16
2 analysts +1q $-0.14
Lo: $-0.18 Hi: $-0.09
2 analysts +1y $0.15
Lo: $0.14 Hi: $0.17
2 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days